ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ACRV Acrivon Therapeutics Inc

9.465
-0.035 (-0.37%)
Last Updated: 13:27:35
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Acrivon Therapeutics Inc ACRV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.035 -0.37% 9.465 13:27:35
Open Price Low Price High Price Close Price Prev Close
9.50 7.80 10.12 9.50
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/24/202416:01GLOBEAcrivon Therapeutics Reports Initial Positive Clinical Data..
4/16/202420:01GLOBEAcrivon Therapeutics to Host Corporate R&D Event..
4/10/202408:00GLOBEAcrivon Therapeutics Presents Data at AACR Annual Meeting..
4/09/202407:00GLOBEAcrivon Therapeutics Announces $130 Million Private..
3/28/202408:00GLOBEAcrivon Therapeutics Reports Fourth Quarter and Full Year..
3/06/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
3/05/202416:30GLOBEAcrivon Therapeutics to Present Data at AACR Annual Meeting..
3/04/202408:15EDGAR2Form 8-K - Current report
3/04/202408:00GLOBEAcrivon Therapeutics Appoints Santhosh Palani, Ph.D., CFA,..
2/27/202408:00GLOBEAcrivon Therapeutics to Participate in a Panel Discussion at..
2/16/202417:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202417:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202417:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202417:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202417:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202417:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202415:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202408:27EDGAR2Form 8-K - Current report
2/08/202408:00GLOBEAcrivon Therapeutics Appoints Seasoned Industry Executive..
2/06/202408:00GLOBEAcrivon Therapeutics to Present at the Oppenheimer 34th..
1/19/202416:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/12/202416:00GLOBEAcrivon Therapeutics Announces Inducement Grants Under..
1/08/202407:28EDGAR2Form 8-K - Current report
1/04/202408:00GLOBEAcrivon Therapeutics to Present at the 42nd Annual J.P...
12/18/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
12/08/202316:21EDGAR2Form 8-K - Current report
12/01/202316:35EDGAR2Form S-3 - Registration statement under Securities Act of..
11/28/202308:58DJNAcrivon Therapeutics Gets FDA's Breakthrough Designation for..
11/28/202308:00GLOBEAcrivon Therapeutics Announces FDA has Granted Breakthrough..
11/21/202308:00GLOBEAcrivon Therapeutics Announces Inducement Grant Under Nasdaq..
11/16/202319:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202319:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202319:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202319:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202319:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202319:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/09/202309:12EDGAR2Form 8-K - Current report
11/09/202308:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202308:01GLOBEAcrivon Therapeutics Reports Third Quarter 2023 Financial..
10/19/202319:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/16/202308:00GLOBEAcrivon Therapeutics Presents Data Demonstrating..
9/28/202319:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/28/202319:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/28/202316:05GLOBEAcrivon Therapeutics Announces Inducement Grants Under..
9/19/202316:32GLOBEAcrivon Therapeutics to Highlight its ACR-368 OncoSignature..
9/05/202317:23EDGAR2Form 8-K - Current report
9/05/202316:05GLOBEAcrivon Therapeutics Announces ACR-2316, a Novel Dual WEE1..
8/30/202308:00GLOBEAcrivon Therapeutics to Participate in Two Investor..
8/23/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock